Across TCGA pan-cancer cohorts, ANKRD19P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated ANKRD19P data layer compared with 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ANKRD19P RNA is associated with better overall survival. In most high-consensus cancer types, elevated ANKRD19P expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.

HNSC, CESC, and UCEC are the cancer types where ANKRD19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.849	0.716	.002	69	view →
CESC	DFS	Tertile	All	0.812	0.608	<.001	64	view →
UCEC	DFS	Tertile	All	0.701	0.624	.007	60	view →
UVM	DFS	Tertile	II,III,IV	0.336	0.913	<.001	54	view →
LUSC	OS	Quartile	All	0.845	0.699	.002	54	view →
BRCA	OS	Median	III,IV	0.893	0.772	.006	45	view →
UCS	OS	Median	IV	0.302	0.817	.002	40	view →
PAAD	OS	Tertile	All	0.556	0.233	.002	39	view →
ACC	DFS	Median	All	0.241	0.642	<.001	35	view →
KIRC	DFS	Quartile	II,III,IV	0.598	0.792	.001	35	view →
LIHC	DFS	Median	II,III,IV	0.247	0.413	.018	17	view →
SKCM	OS	Quartile	IV	0.781	0.224	.003	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: ANKRD19P tumor-vs-normal RNA expression · all ANKRD19P data types